XSHE
002173
Market cap1.13bUSD
Oct 09, Last price
16.77CNY
1D
-1.93%
1Q
-4.55%
Jan 2017
-15.67%
IPO
50.82%
Name
Innovative Medical Management Co Ltd
Chart & performance
P/E
—
P/S
9.48
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.60%
Rev. gr., 5y
1.52%
Revenues
781m
-4.29%
Net income
-35m
L-62.90%
CFO
76m
P
Dividend
Jun 25, 20180.10025 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Zhuji, China, since its establishment in 1997, Innovation Medical Management Co., Ltd. operates a network of urban healthcare facilities within China, covering both specialized and general hospital services.
Key people
Xiaoming Wu
Chief Financial Officer · since 2016
Jinming Tian
Vice President, Secretary of the Board · since 2017
Lidan Guo
Secretary of the Board · since 2022
Haijun Chen
President, Director · since 2013
Guang Ruan
Director · since 2013
Songtao Wang
Director · since 2007
Wenqiang Chen
Independent Director · since 2023
Jinxue Fan
Independent Director · since 2012
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||